Tag Archives: Nasdaq

Introduction to Functional Respiratory Imaging (FRI) for Investors and Market Analysts

FLUIDDA is delighted to invite you to a dedicated session discussing her proprietary Functional Respiratory Imaging (FRI) technology and its application in drug and device development.

During the presentation FLUIDDA’s CEO, Dr. Jan De Backer, will present the technology and explain how it can be used to assess the potential of new respiratory drugs and devices. Some recent examples in Idiopathic Pulmonary Fibrosis (IPF) and Chronic Obstructive Pulmonary Disease (COPD) will be highlighted and an update on the regulatory status of FRI will provided.

The primary target audience for the session consists of market analysts and investors, however anyone with an interest in therapeutic development in respiratory medicine is welcome to register.

Kindly register by providing the following information, seating is limited:

Fields marked with an * are required

 

Fluidda NV

Groeningenlei 132

2550 Kontich

Belgium

BE 0877 160 706

Tel: +32/(0)3 450 87 20

Fax: +32/(0)3 450 87 29

info@fluidda.com

Fluidda NV

Groeningenlei 132

2550 Kontich

Belgium

BE 0877 160 706

Tel: +32/(0)3 450 87 20

Fax: +32/(0)3 450 87 29

info@fluidda.com

FLUIDDA, Inc

675 US Highway One
North Brunswick, NJ 08902
United States

FLUIDDA, Inc

675 US Highway One
North Brunswick, NJ 08902
United States

FLUIDDA India

Medical Imaging pvt ltd
A-95/96, DGP Nagar -2, Ambad
Nashik 422010
India

FLUIDDA India

Medical Imaging pvt ltd
A-95/96, DGP Nagar -2, Ambad
Nashik 422010
India

All content © FLUIDDA 2017